Shenzhen Nuokang Raises $10 Million for Continuous Blood Pressure Device

Shenzhen Nuokang Medical Equipment, a company that has developed a continuous, non-invasive blood pressure measurement device, raised $10 million in a funding led by JD Capital. JD Capital, founded in 2007 and headquartered in Beijing, is a China venture capital and private equity firm. Nuokang will use the proceeds to improve the technology of its device, which is already approved in China, and to launch the device in China, the US and Europe. More details... Share this with colleagues: // //